BROMFENAC SODIUM
| Brand name | BROMSITE |
|---|---|
| Active ingredient | BROMFENAC SODIUM |
| Strength | EQ 0.075% ACID |
| Dosage form | SOLUTION/DROPS |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | April 2016 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| RE50218 | March 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.